Brief: Hyloris Pharmaceuticals: Distribution Agreements For Maxigesic IV In UK And Hong Kong
Nov 4 (Reuters) - Hyloris Pharmaceuticals SA HYL.BR :
* DISTRIBUTION AGREEMENTS FOR MAXIGESIC® IV IN UK AND HONG
KONG
* COMMERCIAL SALES EXPECTED TO COMMENCE IN 2022
* ANNOUNCES THAT ITS PARTNER, AFT PHARMACEUTICALS ("AFT"),
HAS
SIGNED EXCLUSIVE DISTRIBUTION AND SUPPLY AGREEMENTS FOR
MAXIGESIC® IV
Source text : https://bit.ly/2I3T0SH
Further company coverage: HYL.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Hyloris Pharmaceuticals SA
See all newsEurope Research Roundup: Akzo Nobel, MTU Aero Engines, Symrise
Brief: Hyloris Pharmaceuticals Says It Obtains Exclusive License Rights In Europe & Turkey From Arbormed For Its Wilson's Disease Therapy
Brief: Hyloris Announces Partnership With Rosemont Pharmaceuticals For Atomoxetine Oral Solution In The U.S.
Brief: Hyloris Announces Positive Study Results For Dofetilide IV
Brief: Hyloris Pharmaceuticals SA Says HY 2024 Revenues (Royalties And Milestones) Increased To EUR 4,2 Million